The total return over the past 12 months is -51.37% vs. +16.94% for the S&P 500. So far it's up -23.16% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (51.37%) | (32.58%) | (44.24%) | N/A | N/A | N/A |
| Total Return CAGR | (51.37%) | (32.58%) | (44.24%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Adicet Bio, Inc. (ACET)
| Year | Start price | End price | ACET Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $8.42 | $6.47 | (23.16%) | +14.51% | (37.67%) |
| 2025 | $15.39 | $8.42 | (45.29%) | +17.72% | (63.01%) |
| 2024 | $30.24 | $15.39 | (49.11%) | +24.89% | (74.00%) |
| 2023 | $143.04 | $30.24 | (78.86%) | +26.19% | (105.05%) |
| 2022 | $279.84 | $143.04 | (48.89%) | (18.17%) | (30.72%) |
| 2021 | $224.80 | $279.84 | +24.48% | +28.74% | (4.26%) |
| 2020 | $166.88 | $224.80 | +34.71% | +18.37% | +16.34% |
| 2019 | $965.44 | $166.88 | (82.71%) | +31.22% | (113.93%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
